Skip to main content
. 2022 Mar 24;127(2):202–210. doi: 10.1038/s41416-022-01784-9

Table 1.

Clinical correlation of KAT6A expression in HCC (n = 106).

Clinical parameters Cases Expression level P-value
(n) KAT6Ahigh (n = 53) KAT6Alow (n = 53) (*p < 0.05)
Age(years)
  <60 years 64 29 35 0.233
  ≥60 years 42 24 18
Gender
  Male 81 42 39 0.492
  Female 25 11 14
Tumour size (cm) 0.002*
   <5 cm 58 21 37
  ≥5 cm 48 32 16
Tumour number 0.403
  Solitary 91 44 47
  Multiple 15 9 6
Edmondson 0.020*
  I + II 24 7 17
  III + IV 82 46 36
TNM stage 0.034*
  I + II 83 37 46
  III + IV 23 16 7
Venous infiltration 0.296
  Present 9 6 3
  Absent 97 47 50
AFP 0.353
  <400 ng/ml 24 14 10
  ≥400 ng/ml 82 39 43
HBsAg 0.727
  Positive 97 48 49
  Negative 9 5 4

HCC hepatocellular carcinoma, AFP alpha-fetoprotein, TNM tumour-node-metastasis.

*Bold indicates statistically significant.